세계의 동물용 통증 관리 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 용도별, 동물 유형별, 지역별, 경쟁별(2020-2030년)

Veterinary Pain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Animal Type, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,165,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,535,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 10,960,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 동물용 통증 관리 시장은 2024년에는 29억 4,000만 달러로 평가되었고, 2030년에는 43억 4,000만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR 6.71%로 성장할 것으로 예측됩니다.

이 시장은 유전성 질환이나 결핍증 등, 동물의 통증성 및 염증성 질환의 이환율 상승에 견인되어 현저한 확대를 보이고 있습니다. 이러한 유병률 증가는, 동물의 건강과 복지에 대한 의식 고조와 맞물려, 효율적이고 이용하기 쉬운 통증 관리 솔루션에 대한 수요를 촉진하고 있습니다. 특히 도시 지역에서는 저렴한 치료와 수의학적 인프라의 확충이 중시되어 도입이 증가하고 있습니다. 반려동물의 사육율이 계속 상승하고 치료에 대한 기대가 높아짐에 따라 포괄적이고 예방적인 수의학적 케어로의 폭넓은 전환도 시장의 이익이 되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	29억 4,000만 달러
시장 규모(2030년)	43억 4,000만 달러
CAGR(2025-2030년)	6.71%
급성장 부문	반려동물
최대 시장	북미

시장 성장 촉진요인

반려동물 사육 증가 및 반려동물 지출 증가

주요 시장 과제

지방 및 저소득 지역에서 동물용 통증 관리에 대한 접근 제한

주요 시장 동향

약물 전달 시스템 및 비침습적 치료의 진보

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 동물용 통증 관리 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 제품별(의약품, 의료기기)
  • 용도별(관절통, 암성 통증, 수술 후 통증, 기타)
  • 동물 유형별(반려동물, 가축)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 제품별
  • 용도별
  • 동물 유형별
  • 지역별

제6장 북미의 동물용 통증 관리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 동물용 통증 관리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 동물용 통증 관리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 동물용 통증 관리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 동물용 통증 관리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 최근 동향
• 합병 및 인수
• 제품 출시

제13장 세계의 동물용 통증 관리 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협 및 서비스

제15장 경쟁 구도

• Boehringer Ingelheim International GmbH
• Zoetis Inc.

제15장 3 Elanco Animal Health Incorporated

• Norbrook Laboratories Limited
• SeQuent Scientific Limited
• Merck & Co., Inc.
• Dechra Pharmaceuticals Plc
• Vetoquinol S.A.
• Ceva Sante Animale SA
• Chanelle Pharma Group Ltd

제16장 전략적 제안

제17장 기업 소개 및 면책사항

AJY

영문 목차

영문목차

The Global Veterinary Pain Management Market was valued at USD 2.94 billion in 2024 and is projected to reach USD 4.34 billion by 2030, growing at a CAGR of 6.71% during the forecast period. The market is witnessing notable expansion driven by a rising incidence of painful and inflammatory conditions in animals, such as hereditary disorders and deficiency diseases. This growing prevalence, coupled with heightened awareness around animal health and welfare, is fostering demand for efficient and accessible pain management solutions. Urban regions, in particular, are seeing increased adoption due to the emphasis on affordable treatments and better veterinary infrastructure. As companion animal ownership continues to rise and treatment expectations evolve, the market is also benefiting from a broader shift toward comprehensive and preventive veterinary care.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.94 Billion
Market Size 2030	USD 4.34 Billion
CAGR 2025-2030	6.71%
Fastest Growing Segment	Companion Animal
Largest Market	North America

Key Market Drivers

Increasing Pet Ownership and Companion Animal Expenditures

The surge in pet ownership globally, especially in both developed and emerging economies, is significantly propelling the veterinary pain management market. Pets, particularly cats and dogs, are increasingly seen as integral family members, resulting in higher spending on their healthcare needs. This trend is encouraging pet owners to seek advanced treatments for both acute and chronic pain conditions, thereby increasing the demand for veterinary pain management solutions.

Key Market Challenges

Limited Access to Veterinary Pain Management in Rural and Low-Income Regions

One of the foremost challenges in the global veterinary pain management market is the limited availability of services and medications in rural and low-income areas. These regions often lack essential veterinary infrastructure, skilled professionals, and necessary medications. In low- and middle-income countries (LMICs), veterinary care is largely reactive and lacks emphasis on pain relief. The World Organisation for Animal Health (WOAH) indicates that over 45% of surveyed countries report insufficient veterinary service coverage in rural zones, primarily due to limited funding. Additionally, cultural perceptions and a lack of education on animal pain further contribute to the under-treatment of painful conditions. Advanced pain-relief therapies like laser treatment or multimodal analgesic regimens are rarely economically feasible for livestock owners in these areas. Furthermore, national health budgets in LMICs typically allocate minimal resources to veterinary care, with little focus on pain management, hindering market growth.

Key Market Trends

Advancements in Drug Delivery Systems and Non-Invasive Therapies

Technological innovations in drug delivery and therapy methods are transforming the landscape of veterinary pain management. The market is witnessing a shift from traditional oral and injectable drugs toward more animal-friendly formats like chewable tablets, transdermal patches, and long-acting injectables. These innovations offer improved efficacy, easier administration, and greater compliance. Sustained-release formulations, for instance, provide long-term relief with fewer doses, proving especially effective for chronic conditions such as osteoarthritis. Non-invasive therapies like cold laser therapy, pulsed electromagnetic field (PEMF) therapy, and acupuncture are gaining popularity as they minimize reliance on pharmaceutical interventions. Such approaches are appealing to pet owners looking to avoid long-term drug use due to concerns about side effects. Support from government-funded research initiatives in countries like the U.S., Canada, and the UK is accelerating these advancements, making pain management both more effective and accessible.

Key Market Players

• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Elanco Animal Health Incorporated
• Norbrook Laboratories Limited
• SeQuent Scientific Limited
• Merck & Co., Inc.
• Dechra Pharmaceuticals Plc
• Vetoquinol S.A.
• Ceva Sante Animale SA
• Chanelle Pharma Group Ltd

Report Scope:

In this report, the Global Veterinary Pain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Pain Management Market, By Product:

• Medications
• Medical Devices

Veterinary Pain Management Market, By Application:

• Joint Pain
• Cancer Pain
• Postoperative Pain
• Others

Veterinary Pain Management Market, By Animal Type:

• Companion Animal
• Livestock Animal

Veterinary Pain Management Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Pain Management Market.

Available Customizations:

Global Veterinary Pain Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Pain Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Medications, Medical Devices)
  • 5.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 5.2.3. By Animal Type (Companion Animal, Livestock Animal)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By Animal Type
  • 5.3.4. By Region

6. North America Veterinary Pain Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Medications v/s Medical Devices)
  • 6.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 6.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Pain Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Animal Type
  • 6.3.2. Mexico Veterinary Pain Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Animal Type
  • 6.3.3. Canada Veterinary Pain Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Animal Type

7. Europe Veterinary Pain Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Medications v/s Medical Devices)
  • 7.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 7.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Veterinary Pain Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Animal Type
  • 7.3.2. Germany Veterinary Pain Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Animal Type
  • 7.3.3. United Kingdom Veterinary Pain Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Animal Type
  • 7.3.4. Italy Veterinary Pain Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Animal Type
  • 7.3.5. Spain Veterinary Pain Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Animal Type

8. Asia-Pacific Veterinary Pain Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Medications v/s Medical Devices)
  • 8.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 8.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Veterinary Pain Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Animal Type
  • 8.3.2. India Veterinary Pain Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Animal Type
  • 8.3.3. South Korea Veterinary Pain Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Animal Type
  • 8.3.4. Japan Veterinary Pain Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Animal Type
  • 8.3.5. Australia Veterinary Pain Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Animal Type

9. South America Veterinary Pain Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Medications v/s Medical Devices)
  • 9.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 9.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Veterinary Pain Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Animal Type
  • 9.3.2. Argentina Veterinary Pain Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Animal Type
  • 9.3.3. Colombia Veterinary Pain Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Animal Type

10. Middle East and Africa Veterinary Pain Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Medications v/s Medical Devices)
  • 10.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 10.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Veterinary Pain Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Animal Type
  • 10.3.2. Saudi Arabia Veterinary Pain Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Animal Type
  • 10.3.3. UAE Veterinary Pain Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Animal Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Veterinary Pain Management Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Zoetis Inc.

15.3 Elanco Animal Health Incorporated

• 15.4. Norbrook Laboratories Limited
• 15.5. SeQuent Scientific Limited
• 15.6. Merck & Co., Inc.
• 15.7. Dechra Pharmaceuticals Plc
• 15.8. Vetoquinol S.A.
• 15.9. Ceva Sante Animale SA
• 15.10. Chanelle Pharma Group Ltd

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료